Fluocinolone acetonide intravitreal implant (Iluvien®) for non-infectious uveitis. HTA ID: 20050
Fluocinolone acetonide intravitreal implant (Iluvien®) is indicated for the prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye.
| NCPE Assessment Process | Complete |
| Rapid review commissioned | 23/11/2020 |
| Rapid review completed | 21/12/2020 |
| Rapid Review outcome | A full HTA is not recommended. The NCPE recommends that fluocinolone acetonide intravitreal implant not be considered for reimbursement at the submitted price*. |
*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.